| . | NGs . | WGs . | Pa . |
|---|---|---|---|
| Total cholesterol, mean ± SD, mg/dL | BL, .04 | ||
| Baseline | 186 ± 46 | 172 ± 49 | .22 |
| At 6 mo | 186 ± 45 | 176 ± 52 | |
| At 12 mo | 184 ± 42 | 181 ± 46 | |
| HDL cholesterol, mean ± SD, mg/dL | BL, .008 | ||
| Baseline | 47 ± 17 | 40 ± 13 | .046 |
| At 6 mo | 48 ± 16 | 41 ± 13 | |
| At 12 mo | 49 ± 15 | 47 ± 15 | |
| TC/HDL, median (IQR) | BL, .10 | ||
| Baseline | 4.1 (3.2–5.1) | 4.3 (3.8–5.3) | .18 |
| At 6 mo | 3.9 (3.1–4.9) | 4.3 (3.3–5.5) | |
| At 12 mo | 3.9 (3.1–4.7) | 4.0 (3.2–5.0) | |
| Triglycerides, median (IQR), mg/dL | BL, .75 | ||
| Baseline | 117 (87–172) | 108 (86–180) | .63 |
| At 6 mo | 112 (80–162) | 119 (88–173) | |
| At 12 mo | 107 (79–159) | 110 (73–174) | |
| Triglycerides/HDL | BL, .16 | ||
| Baseline | 2.7 (1.6–4.7) | 3.0 (2.0–6.1) | .15 |
| At 6 mo | 2.5 (1.5–4.1) | 2.9 (1.9–5.1) | |
| At 12 mo | 2.3 (1.5–4.0) | 2.7 (1.4–4.8) | |
| Blood glucose, mean ± SD, mg/dL | BL, .64 | ||
| Baseline | 91 ± 27 | 90 ± 16 | .49 |
| At 6 mo | 92 ± 23 | 92 ± 16 | |
| At 12 mo | 93 ± 22 | 93 ± 15 |
| . | NGs . | WGs . | Pa . |
|---|---|---|---|
| Total cholesterol, mean ± SD, mg/dL | BL, .04 | ||
| Baseline | 186 ± 46 | 172 ± 49 | .22 |
| At 6 mo | 186 ± 45 | 176 ± 52 | |
| At 12 mo | 184 ± 42 | 181 ± 46 | |
| HDL cholesterol, mean ± SD, mg/dL | BL, .008 | ||
| Baseline | 47 ± 17 | 40 ± 13 | .046 |
| At 6 mo | 48 ± 16 | 41 ± 13 | |
| At 12 mo | 49 ± 15 | 47 ± 15 | |
| TC/HDL, median (IQR) | BL, .10 | ||
| Baseline | 4.1 (3.2–5.1) | 4.3 (3.8–5.3) | .18 |
| At 6 mo | 3.9 (3.1–4.9) | 4.3 (3.3–5.5) | |
| At 12 mo | 3.9 (3.1–4.7) | 4.0 (3.2–5.0) | |
| Triglycerides, median (IQR), mg/dL | BL, .75 | ||
| Baseline | 117 (87–172) | 108 (86–180) | .63 |
| At 6 mo | 112 (80–162) | 119 (88–173) | |
| At 12 mo | 107 (79–159) | 110 (73–174) | |
| Triglycerides/HDL | BL, .16 | ||
| Baseline | 2.7 (1.6–4.7) | 3.0 (2.0–6.1) | .15 |
| At 6 mo | 2.5 (1.5–4.1) | 2.9 (1.9–5.1) | |
| At 12 mo | 2.3 (1.5–4.0) | 2.7 (1.4–4.8) | |
| Blood glucose, mean ± SD, mg/dL | BL, .64 | ||
| Baseline | 91 ± 27 | 90 ± 16 | .49 |
| At 6 mo | 92 ± 23 | 92 ± 16 | |
| At 12 mo | 93 ± 22 | 93 ± 15 |
Abbreviations: BL, baseline; HDL, high-density lipoprotein; IQR, interquartile range; NGs, nongainers; TC, total cholesterol; WGs, weight gainers.
aTest for repeated measures, adjusted for age, sex, baseline statin use, regimen type.
| . | NGs . | WGs . | Pa . |
|---|---|---|---|
| Total cholesterol, mean ± SD, mg/dL | BL, .04 | ||
| Baseline | 186 ± 46 | 172 ± 49 | .22 |
| At 6 mo | 186 ± 45 | 176 ± 52 | |
| At 12 mo | 184 ± 42 | 181 ± 46 | |
| HDL cholesterol, mean ± SD, mg/dL | BL, .008 | ||
| Baseline | 47 ± 17 | 40 ± 13 | .046 |
| At 6 mo | 48 ± 16 | 41 ± 13 | |
| At 12 mo | 49 ± 15 | 47 ± 15 | |
| TC/HDL, median (IQR) | BL, .10 | ||
| Baseline | 4.1 (3.2–5.1) | 4.3 (3.8–5.3) | .18 |
| At 6 mo | 3.9 (3.1–4.9) | 4.3 (3.3–5.5) | |
| At 12 mo | 3.9 (3.1–4.7) | 4.0 (3.2–5.0) | |
| Triglycerides, median (IQR), mg/dL | BL, .75 | ||
| Baseline | 117 (87–172) | 108 (86–180) | .63 |
| At 6 mo | 112 (80–162) | 119 (88–173) | |
| At 12 mo | 107 (79–159) | 110 (73–174) | |
| Triglycerides/HDL | BL, .16 | ||
| Baseline | 2.7 (1.6–4.7) | 3.0 (2.0–6.1) | .15 |
| At 6 mo | 2.5 (1.5–4.1) | 2.9 (1.9–5.1) | |
| At 12 mo | 2.3 (1.5–4.0) | 2.7 (1.4–4.8) | |
| Blood glucose, mean ± SD, mg/dL | BL, .64 | ||
| Baseline | 91 ± 27 | 90 ± 16 | .49 |
| At 6 mo | 92 ± 23 | 92 ± 16 | |
| At 12 mo | 93 ± 22 | 93 ± 15 |
| . | NGs . | WGs . | Pa . |
|---|---|---|---|
| Total cholesterol, mean ± SD, mg/dL | BL, .04 | ||
| Baseline | 186 ± 46 | 172 ± 49 | .22 |
| At 6 mo | 186 ± 45 | 176 ± 52 | |
| At 12 mo | 184 ± 42 | 181 ± 46 | |
| HDL cholesterol, mean ± SD, mg/dL | BL, .008 | ||
| Baseline | 47 ± 17 | 40 ± 13 | .046 |
| At 6 mo | 48 ± 16 | 41 ± 13 | |
| At 12 mo | 49 ± 15 | 47 ± 15 | |
| TC/HDL, median (IQR) | BL, .10 | ||
| Baseline | 4.1 (3.2–5.1) | 4.3 (3.8–5.3) | .18 |
| At 6 mo | 3.9 (3.1–4.9) | 4.3 (3.3–5.5) | |
| At 12 mo | 3.9 (3.1–4.7) | 4.0 (3.2–5.0) | |
| Triglycerides, median (IQR), mg/dL | BL, .75 | ||
| Baseline | 117 (87–172) | 108 (86–180) | .63 |
| At 6 mo | 112 (80–162) | 119 (88–173) | |
| At 12 mo | 107 (79–159) | 110 (73–174) | |
| Triglycerides/HDL | BL, .16 | ||
| Baseline | 2.7 (1.6–4.7) | 3.0 (2.0–6.1) | .15 |
| At 6 mo | 2.5 (1.5–4.1) | 2.9 (1.9–5.1) | |
| At 12 mo | 2.3 (1.5–4.0) | 2.7 (1.4–4.8) | |
| Blood glucose, mean ± SD, mg/dL | BL, .64 | ||
| Baseline | 91 ± 27 | 90 ± 16 | .49 |
| At 6 mo | 92 ± 23 | 92 ± 16 | |
| At 12 mo | 93 ± 22 | 93 ± 15 |
Abbreviations: BL, baseline; HDL, high-density lipoprotein; IQR, interquartile range; NGs, nongainers; TC, total cholesterol; WGs, weight gainers.
aTest for repeated measures, adjusted for age, sex, baseline statin use, regimen type.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
